Chemistry and biology of wortmannin

Organic and Biomolecular Chemistry

Volumn 3, Issue 11, 2005, Pages 2053-2061

  Wipf, Peter ^a   Halter, Robert J ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Myriad Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHILICITY; EPIDERMAL GROWTH; STEROIDAL FURANS; WORTMANNIN;

BIOLOGICAL MATERIALS; CELLS; DEGRADATION; ENZYME INHIBITION; GROWTH KINETICS; MUSCULOSKELETAL SYSTEM; SKIN; X RAY CRYSTALLOGRAPHY;

DRUG PRODUCTS;

ADENOSINE TRIPHOSPHATE; ANDROSTANE DERIVATIVE; ENZYME INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; ANDROSTADIENES; ENZYME INHIBITORS; MODELS, MOLECULAR;

EID: 20844458056     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b504418a     Document Type: Article

References (73)

1. P. W. Brian, P. J. Curtis, H. G. Hemming and G. L. F. Norris, Trans. Brit. Mycol. Soc., 1957, 40, 365-368.
2. J. MacMillan, A. E. Vanstone and S. K. Yeboah, J. Chem. Soc., Chem. Commun., 1968, 613-614.
3. (a) J. MacMillan, T. J. Simpson and S. K. Yeboah, J. Chem. Soc., Chem. Commun., 1972, 1063;
4. (b) J. MacMillan, A. E. Vanstone and S. K. Yeboah, J. Chem. Soc., Perkin Trans. 1, 1972, 2898-2903;
5. (c) J. MacMillan, T. J. Simpson, A. E. Vanstone and S. K. Yeboah, J. Chem. Soc., Perkin Trans. 1, 1972, 2892-2898.
6. T. J. Petcher, H.-P. Weber and Z. Kis, J. Chem. Soc., Chem. Commun., 1972, 1061-1062.
7. For a review of steroidal furans, see: J. R. Hanson, Nat. Prod. Rep., 1995, 12, 381-384.
8. (a) P. Wipf and A. D. Kerekes, J. Nat. Prod, 2003, 66, 716-718;
9. (b) E. Sakuno, K. Yabe, T. Hamasaki and H. Nakajima, J. Nat. Prod., 2000, 63, 1677-1678.
10. D. M. Roll and P. J. Scheuer, J. Am. Chem. Soc., 1983, 105, 6177-6188.
11. H. Nakamura, J. Kobayashi, M. Kobayashi, Y. Ohizumi and Y. Hirata, Chem. Lett., 1985, 713-716.
12. See also: Y. C. Shen, C. V. S. Prakash and J.-H. Guh, Tetrahedron Lett., 2004, 45, 2463-2466.
13. S. P. Maddaford, N. G. Andersen, W. A. Cristofoli and B. A. Keay, J. Am. Chem. Soc., 1996, 118, 10766-10773.
14. M. Nakamura, T. Kakuda, Y. Oba, M. Ojika and H. Nakamura, Bioorg. Med. Chem., 2003, 11, 3077-3082.
15. H. Fujiwara, K. Matsunaga, M. Saito, S. Hagiya, K. I. Furukawa, H. Nakamura and Y. Ohizumi, Eur. J. Pharmacol., 2001, 413, 37-45.
16. M. A. Lyon, A. P. Ducruet, P. Wipf and J. S. Lazo, Nat. Rev. Drug Discovery, 2002, 1, 961-976.
17. S. Cao, C. Foster, M. Brisson, J. S. Lazo and D. G. I. Kingston, Bioorg. Med. Chem., 2005, 13, 999-1003.
18. Y. Zhu, W. Y. Yoshida, M. Kelly-Borges and P. J. Scheuer, Heterocycles, 1998, 49, 355-360.
19. K. A. Alvi, J. Rodriguez, M. C. Diaz, R. Moretti, R. S. Wilhelm, R. H. Lee, D. L. Slate and P. Crews, J. Org. Chem., 1993, 58, 4871-4880.
20. R. Kapeller and L. C. Cantley, BioEssays, 1994, 16, 565-576.
21. L. Rameh and L. C. Cantley, J. Biol. Chem., 1999, 274, 8347-8350.
22. H. Yano, S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura and Y. Matsuda, J. Biol. Chem., 1993, 34, 25846-25856.
23. For some preliminary metabolism studies, see: J. L. Holleran, J. Fourcade, M. J. Egorin, J. L. Eiseman, R. A. Parise, S. M. Musser, K. D. White, J. M. Covey, G. L. Forrest and S.-S. Pan, Drug Metab. Dispos., 2004, 32, 490-496.
24. A. Giaccia, B. G. Sum and R. S. Johnson, Nat. Rev. Drug Discovery, 2003, 2, 803-811.
25. Y. Liu, K. R. Shreder, W. Gai, S. Corral, D. K. Ferris and J. S. Rosenblum, Chem. Biol., 2005, 12, 99-107.
26. G. J. Brunn, J. Williams, C. Sabers, G. Wiederrecht, J. C. Lawrence and R. T. Abraham, EMBO J., 1996, 15, 5256-5267.
27. S. Boulton, S. Kyle, L. Yalcintepe and B. W. Durkacz, Carcinogenesis, 1996, 17, 2285-2290.
28. A. Sekulic, C. C. Hudson, J. L. Homme, P. Yin, D. M. Otterness, L. M. Karnitz and R. T. Abraham, Cancer Res., 2000, 60, 3504-3513.
29. S. Nakanishi, S. Kakita, I. Takahashi, K. Kawahara, E. Tsukuda, T. Sano, K. Yamada, M. Yoshida, H. Kase, Y. Matsuda, Y. Hashimoto and Y. Nonomura, J. Biol. Chem., 1992, 267, 2157-2163.
30. S. Corvera and M. P. Czech, Trends Cell. Biol., 1998, 8, 442-446.
31. M. P. Wymann, G. Bulgarelli-Leva, M. J. Zvelebil, L. Pirola, B. VanHaese-broeck, M. D. Waterfield and G. Panayotou, Mol. Cell. Biol., 1996, 16, 1722-1733.
32. B. H. Norman, J. Paschal and C. J. Vlahos, Bioorg. Med. Chem. Lett., 1995, 5, 1183-1186.
33. E. H. Walker, M. E. Pacold, O. Perisic, L. Stephens, P. T. Hawkins, M. P. Wymann and R. L. Williams, Mol. Cell, 2000, 6, 909-919.
34. D. Wiesinger, H. U. Gubler, W. Haefliger and D. Hauser, Experientia, 1974, 30, 135-136.
35. (a) W. Haefliger and D. Hauser, Helv. Chim. Acta, 1973, 56, 2901-2904;
36. (b) W. Haefliger, Z. Kis and D. Hauser, Helv. Chim. Acta, 1975, 58, 1620-1628;
37. (c) W. Haefliger and D. Hauser, Helv. Chim. Acta, 1975, 58, 1629-1633.
38. (a) J. A. Dodge, H. U. Byrant, J. Kim, W. F. Matter, B. H. Norman, U. Srinivasan, C. J. Vlahos and M. Sato, Bioorg. Med. Chem. Lett., 1995, 5, 1713-1718;
39. (b) B. H. Norman, C. Shih, J. E. Toth, J. E. Ray, J. A. Dodge, D. W. Johnson, P. G. Rutherford, R. M. Schultz, J. F. Worzalla and C. J. Vlahos, J. Med. Chem., 1996, 39, 1106-1111;
40. (c) L. C. Creemer, H. A. Kirst, C. J. Vlahos and R. M. Schultz, J. Med. Chem., 1996, 39, 5021-5024.
41. P. Wipf, D. J. Minion, R. J. Halter, M. I. Berggren, C. B. Ho, G. G. Chiang, L. Kirkpatrick, R. Abraham and G. Powis, Org. Biomol. Chem., 2004, 2, 1911-1920.
42. N. T. Ihle, R. Williams, S. Chow, W. Chew, M. I. Berggren, G. Paine-Murrieta, D. J. Minion, R. J. Halter, P. Wipf, R. Abraham, L. Kirkpatrick and G. Powis, Mol. Cancer Ther., 2004, 3, 763-772.
43. R. Maltais, M. R. Tremblay, L. C. Ciobanu and D. Poirier, J. Comb. Chem., 2004, 6, 443-456.
44. S. Sato, M. Nakada and M. Shibasaki, Tetrahedron Lett., 1996, 73, 6141-6144.
45. T. Mizutani, S. Honzawa, S.-y. Tosaki and M. Shibasaki, Angew. Chem., Int. Ed., 2002, 41, 4680-4681.
46. C. A. Broka and B. Ruhland, J. Org. Chem., 1992, 57, 4888-4894.
47. F. E. S. Souza and R. Rodrigo, Chem. Commun., 1999, 1947-1948.
48. E. A. Anderson, E. J. Alexanian and E. J. Sorensen, Angew. Chem., Int. Ed., 2004, 43, 1998-2001.
49. (a) H. S. Sutherland, F. E. S. Souza and R. G. A. Rodrigo, J. Org. Chem., 2001, 66, 3639-3641;
50. (b) A. Kojima, T. Takemoto, M. Sodeoka and M. Shibasaki, Synthesis, 1998, 581-589;
51. (c) N. Harada, T. Sugioka, Y. Ando, H. Uda and T. Kuriki, J. Am. Chem. Soc., 1988, 110, 8483-8487.
52. A. S. Caselli, D. J. Collins and G. M. Stone, Aust. J. Chem., 1982, 35, 799-808.
53. W. Haefliger, Z. Kis and D. Hauser, Helv. Chim. Acta, 1975, 58, 1620-1628.
54. F. E. S. Souza and R. Rodrigo, Chem. Commun., 1999, 1947-1948.
55. R. Carlini, K. Higgs, C. Older, S. Randhawa and R. Rodrigo, J. Org. Chem., 1997, 62, 2330-2331.
56. S. H. Lecker, N. H. Nguyen and K. P. C. Vollhardt, J. Am. Chem. Soc., 1986, 108, 856-858.
57. P. Wipf, in Claisen Rearrangements, vol. 5, ed. B. M. Trost, I. Fleming, and L. A. Paquette, Oxford, 1991, pp. 827-874.
58. T. M. Trnka and R. H. Grubbs, Acc. Chem. Res., 2001, 34, 18-29.
59. T. J. Donohoe, K. Blades, P. R. Moore, M. J. Waring, J. J. G. Winter, M. Helliwell, N. J. Newcombe and G. Stemp, J. Org. Chem., 2002, 67, 7946-7956.
60. R. Carlini, K. Higgs, C. Older, S. Randhawa and R. Rodrigo, J. Org. Chem., 1997, 62, 2330-2331.
61. A. Kojima, T. Takemoto, M. Sodeoka and M. Shibasaki, Synthesis, 1998, 581.
62. N. Toyooka, M. Nagaoka, E. Sasaki, H. Qin, H. Kakuda and H. Nemoto, Tetrahedron, 2002, 58, 6097-6102.
63. H. S. Sutherland, K. C. Higgs, N. J. Taylor and R. Rodrigo, Tetrahedron, 2001, 57, 309-317.
64. A. Kojima, T. Takemoto, M. Sodeoka and M. Shibasaki, J. Org. Chem., 1996, 61, 4876-4877.
65. (a) D. G. I. Kingston and D. J. Newman, Curr. Opin. Drug Discovery Dev., 2005, 8, 207-227;
66. (b) P. Wipf, J. T. Reeves and B. W Day, Curr. Pharm. Des., 2004, 10, 1417-1437;
67. (c) K. C. Nicolaou, T. Montagnon and S. A. Snyder, Chem. Commun., 2003, 551-564.
68. For example, in stent implantation: R.-H. Zhou, T.-S. Lee, T.-C. Tsou, F. Rannou, Y.-S. Li, C. Shu and J. Y. J. Shyy, Arterioscler., Thromb., Vase. Biol., 2003, 23, 2015-2020; or in targeting HIF-1: ref. 21.
69. I. Paterson, O. Delgado, G. J. Florence, I. Lyothier, M. O'Brien, J. P. Scott and N. Sereinig, J. Org. Chem., 2005, 70, 150-160.
70. (a) T. J. Simpson, M. W. Lunnon and J. MacMillan, J. Chem. Soc., Perkin Trans. 1, 1979, 931-934;
71. (b) J. R. Hanson, M. A. O'Leary and H. J. Wadsworth, J. Chem. Soc., Perkin Trans. 1, 1983, 867-870;
72. (c) W. S. Golder and T. R. Watson, J. Chem. Soc., Perkin Trans. 1, 1980, 422-425;
73. (d) M. M. Blight, J. J. W. Coppen and J. F. Grove, J. Chem. Soc., Chem. Commun., 1968, 1117-1118.